These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
67 related articles for article (PubMed ID: 13528912)
1. [Relation of blood eosinophil levels to Charcot-Leyden crystals in feces]. BRUMPT LC; HO-THI-SANG Sang; 1957; 28(5):479-83. PubMed ID: 13528912 [No Abstract] [Full Text] [Related]
2. Identification of human eosinophil lysophospholipase as the constituent of Charcot-Leyden crystals. Weller PF; Goetzl EJ; Austen KF Proc Natl Acad Sci U S A; 1980 Dec; 77(12):7440-3. PubMed ID: 6261258 [TBL] [Abstract][Full Text] [Related]
3. Significance of Charcot Leyden crystals in liver cytology-A case report. Thakral D; Agarwal P; Saran RK; Saluja S Diagn Cytopathol; 2015 May; 43(5):392-4. PubMed ID: 25350873 [TBL] [Abstract][Full Text] [Related]
4. Hypereosinophilic syndrome with abundant Charcot-Leyden crystals in spleen and lymph nodes. Takeda M; Ueki S; Yamamoto Y; Nara M; Fukuchi M; Nakayama K; Omori Y; Takahashi N; Hirokawa M Asia Pac Allergy; 2020 Jul; 10(3):e24. PubMed ID: 32789109 [TBL] [Abstract][Full Text] [Related]
5. Charcot-Leyden crystals. Formation from primate and lack of formation from nonprimate eosinophils. el-Hashimi W Am J Pathol; 1971 Nov; 65(2):311-24. PubMed ID: 5134886 [TBL] [Abstract][Full Text] [Related]
6. Human eosinophil lysophospholipase: the sole protein component of Charcot-Leyden crystals. Weller PF; Bach D; Austen KF J Immunol; 1982 Mar; 128(3):1346-9. PubMed ID: 6173432 [TBL] [Abstract][Full Text] [Related]
7. Expression of lysophospholipase activity by intact human eosinophils and their Charcot-Leyden crystals. Weller PF; Bach D; Austen KF Trans Assoc Am Physicians; 1981; 94():165-71. PubMed ID: 7344218 [No Abstract] [Full Text] [Related]
8. [Interstitial myocarditis with eosinophilic leukocytes, Charcot-Leyden crystals and giant cells]. Chomette G Arch Anat Pathol (Paris); 1967 Mar; 15(1):62. PubMed ID: 6064555 [No Abstract] [Full Text] [Related]
9. FORMATION OF CHARCOT-LEYDEN CRYSTALS IN HUMAN EOSINOPHILS AND BASOPHILS AND STUDY OF THE COMPOSITION OF ISOLATED CRYSTALS. ARCHER GT; BLACKWOOD A J Exp Med; 1965 Jul; 122(1):173-80. PubMed ID: 14325469 [TBL] [Abstract][Full Text] [Related]
10. The human eosinophil Charcot-Leyden crystal protein: biochemical characteristics and measurement by radioimmunoassay. Ackerman SJ; Loegering DA; Gleich GJ J Immunol; 1980 Nov; 125(5):2118-26. PubMed ID: 7430621 [No Abstract] [Full Text] [Related]
12. Comparative properties of the Charcot-Leyden crystal protein and the major basic protein from human eosinophils. Gleich GJ; Loegering DA; Mann KG; Maldonado JE J Clin Invest; 1976 Mar; 57(3):633-40. PubMed ID: 942977 [TBL] [Abstract][Full Text] [Related]
13. Evidence for secretion of human eosinophil granule major basic protein and Charcot-Leyden crystal protein during eosinophil maturation. Butterfield JH; Ackerman SJ; Scott RE; Pierre RV; Gleich GJ Exp Hematol; 1984 Mar; 12(3):163-70. PubMed ID: 6705849 [TBL] [Abstract][Full Text] [Related]